- Home
- Search for Research Summaries, Reviews, and Reports
Noncyclic Chronic Pelvic Pain Therapies for Women
To Receive a Certificate for This Activity
- Read the CME information on this page.
- Review information on the contributor biographies.
- View the presentations in this enduring material.
- Complete the CME posttest (you must answer 7 out of 8 questions correctly).
- Complete and submit the CME registration and evaluation forms.
CME Information
Course Overview
Noncyclic chronic pelvic pain (CPP) is a fairly common condition among women, with estimated prevalence rates ranging from 4-43.4 percent. Despite the wide prevalence of this condition and the associated morbidity, there is no standard treatment algorithm. Empirical treatment, or treatment based on clinician experience and observation as the basis for decision-making, rather than systematic logic or solid evidence, for noncyclic CPP is increasingly recommended as standard initial management.
Multiple surgical and non-surgical interventions are used in clinical practice to manage potential etiologies and to treat pain symptoms. However, the benefits and/or potential harms of these interventions have not been systematically assessed in studies. Additionally, rationale for selecting one intervention over another when an initial treatment approach fails lacks guidance from evidence.
This CME activity covers the systematic review and meta analysis of the current clinical literature, conducted by the Vanderbilt Evidence-based Practice Center, to evaluate the evidence about the comparative effectiveness of surgical and non-surgical therapies in managing noncyclic chronic pelvic pain.
Educational Objectives
At the conclusion of this activity, the participant should be able to:
- Describe the estimated prevalence and etiological factors associated with noncyclic chronic pelvic pain (CPP).
- Evaluate the various comorbidities and psychological and social factors established in the evidence that might occur with noncyclic CPP in making treatment decisions for women with noncyclic CPP.
- Discuss the limitations and knowledge gaps in the current evidence regarding surgical and nonsurgical therapies for CPP in women.
Target Audience
This CME activity is designed to meet the educational needs of primary care physicians, obstetricians and gynecologists, as well as healthcare professionals who treat patients with noncyclic chronic pelvic pain.
Method of Participation
This activity is in PowerPoint file format and is accompanied by talking points and references linked to PubMed abstracts.
To receive a maximum of 1.0 AMA PRA Category 1 Credit(s)™ you should:
- View the presentations in this enduring material.
- Complete the posttest (you must answer 7 out of 8 questions correctly).
- Complete and submit the CME registration and evaluation forms.
The estimated time to complete this activity, including review of the materials, is 1.0 hour(s).
Hardware/software requirements: Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox, and Google Chrome.
If you have questions about the participation process, please e-mail the Office of Continuing Medical Education, cme@bcm.edu or phone 713.798.8237.
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Term of Approval
April 2012 through April 2015. Original release date: April 2012
Peer Review
In February 2012, this continuing medical education online enduring material was reviewed by Jennifer E. Dietrich, MD, MSc, Assistant Professor, Department of Obstetrics and Gynecology, Fellowship Director Pediatric and Adolescent Gynecology, Baylor College of Medicine and Chief of Pediatric and Adolescent Gynecology,Texas Children’s Hospital, Houston, Texas. To ensure the continued scientific relevance of this enduring material, its content will be reviewed again in April 2015.
Disclosures: Advisory committee member for Bayer Pharmaceuticals.
Program Director
Michael Fordis, MD
Sr. Associate Dean
Director, Center for Collaborative and Interactive Technologies
Director, John M. Eisenberg Center for Clinical Decisions and Communications Science
Baylor College of Medicine
Houston, Texas
Disclosures: Nothing to disclose.
Disclaimer
This CME activity is designed for use by healthcare professionals for educational purposes only. Information and opinion offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDA-approved uses and information.
Baylor College of Medicine makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Links are provided to other Internet sites solely for the convenience of users. Once you link to another site, you are subject to the site's terms and conditions of use including copyright and licensing restrictions.
Disclosure
The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support SM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: l) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.
Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.
If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Jennifer E. Dietrich, MD, MSc, Peer Reviewer: Advisory committee member for Bayer Pharmaceuticals.
The following individual(s) has/have reported no financial or other relationships with commercial entities whose products/services may relate to the educational content of this activity:
Geetha Achanta, MSc, PhD, Medical Writer: Nothing to disclose.
Jeffrey C. Andrews, MD, Contributor: Nothing to disclose.
Michael Fordis, MD, Activity Director: Nothing to disclose.
Nila A. Sathe, MA, MLIS, Contributor: Nothing to disclose.
Ronald L. Young, MD, Contributor: Nothing to disclose.
Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with the applicable law.
Baylor College of Medicine requires that all contributors disclose an unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products, and provide adequate scientific and clinical justification for such use. Physicians are urged to fully review all the available data on products or procedures before using them to treat patients.
Acknowledgement of Support
This CME activity is supported by a contract, HHSA290200810015C, from the Agency for Healthcare Research and Quality.